Explore Reviva Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for RVPH. Reviva Pharmaceuticals Schizophrenia Drug Demonstrates Strong ...

On November 14 th, 2024, Reviva Pharmaceutical Holdings, Inc. (NASDAQ:RVPH) reported third quarter 2024 financial and operational results and filed its Form 10-Q with the SEC. Reviva provided ...

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH – Get Free Report) has earned an average recommendation of “Buy” from the seven brokerages that are covering the stock, MarketBeat reports.

Short interest in Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) decreased during the last reporting period, falling from 4.25M to 3.79M. This put 9.1% of the company's publicly available ...

1 Day RVPH -3.68% DJIA -1.69% Russell 2K -2.94% Health Care/Life Sciences -0.37% ...

CUPERTINO, CA – Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH), a clinical-stage pharmaceutical company with a market capitalization of $85.33 million, announced significant changes to its ...

Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

CUPERTINO, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that ...